Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Yee

Showing results (571-580 of 588) with videos related to

Pageof 59
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroidsTimothy I Richardson, Christian A Clarke, Kuo-Long Yu, et al.
Biomedicines|January 8, 2025
RELT Is Upregulated in Breast Cancer and Induces Death in Breast Cancer CellsMaryann Batiste, Bethany Joy, Cara K Yee, et al.
Journal of Medicinal Chemistry|July 31, 2007
Discovery and optimization of p38 inhibitors via computer-assisted drug designDaniel R Goldberg, Ming-Hong Hao, Kevin C Qian, et al.
Angewandte Chemie (International Ed. in English)|May 6, 2015
Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase InhibitorKeith R Fandrick, Wenjie Li, Yongda Zhang, et al.
The Journal of Organic Chemistry|September 9, 2006
Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesisNathan K Yee, Vittorio Farina, Ioannis N Houpis, et al.
Annals of Hematology|November 21, 2024
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.
Journal of Medicinal Chemistry|March 15, 2000
1,2-Dibenzamidobenzene inhibitors of human factor XaD K Herron, T Goodson, M R Wiley, et al.
Journal of the American Chemical Society|November 1, 2016
Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 InhibitorXudong Wei, Bo Qu, Xingzhong Zeng, et al.
Expert Review of Cardiovascular Therapy|October 9, 2018
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolismTarek Nafee, C Michael Gibson, Megan K Yee, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Pageof 59

Showing results (571-580 of 588) with videos related to

Sort By:
Pageof 59
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroidsTimothy I Richardson, Christian A Clarke, Kuo-Long Yu, et al.
Biomedicines|January 8, 2025
RELT Is Upregulated in Breast Cancer and Induces Death in Breast Cancer CellsMaryann Batiste, Bethany Joy, Cara K Yee, et al.
Journal of Medicinal Chemistry|July 31, 2007
Discovery and optimization of p38 inhibitors via computer-assisted drug designDaniel R Goldberg, Ming-Hong Hao, Kevin C Qian, et al.
Angewandte Chemie (International Ed. in English)|May 6, 2015
Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase InhibitorKeith R Fandrick, Wenjie Li, Yongda Zhang, et al.
The Journal of Organic Chemistry|September 9, 2006
Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesisNathan K Yee, Vittorio Farina, Ioannis N Houpis, et al.
Annals of Hematology|November 21, 2024
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.
Journal of Medicinal Chemistry|March 15, 2000
1,2-Dibenzamidobenzene inhibitors of human factor XaD K Herron, T Goodson, M R Wiley, et al.
Journal of the American Chemical Society|November 1, 2016
Sequential C-H Arylation and Enantioselective Hydrogenation Enables Ideal Asymmetric Entry to the Indenopiperidine Core of an 11β-HSD-1 InhibitorXudong Wei, Bo Qu, Xingzhong Zeng, et al.
Expert Review of Cardiovascular Therapy|October 9, 2018
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolismTarek Nafee, C Michael Gibson, Megan K Yee, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Pageof 59